We regulate medicines, medical devices and cosmetics, to promote human and animal health.
Botswana Medicines Regulatory Authority (BoMRA) invites Medical Devices Stakeholders (Manufacturers, Distributors, Authorized Representatives etc.) to
The Medical Devices Unit in the Department of Product Evaluation & Registration at BoMRAwill conduct
The Board and Management at Botswana Medicines Regulatory Authority (BoMRA) wishes to announce the appointment of Shirley Amogelang Pine, as the Director, Human Resource & Organizational Development and Bathusi Kgosietsile as the Director, Product Evaluation and Registration.
As mandated by the Medicines and Related Substances Act of 2013, Botswana Medicines Regulatory Authority
Kindly be reminded that as previously advised in the stakeholder engagement and BoMRA communication of Ref: MRA 6/2/4 Vol. 1(98) , BoMRA has commenced licensing of schedule 4 and complementary medicines importers since January 2023.
The Medical Devices Unit of the Botswana Medicines Regulatory Authority (BoMRA) would like to inform its valued stakeholders that the listing database of medical devices including In-Vitro Diagnostics (IVDs) devices has been published on the BoMRA website.
The Botswana Medicines Regulatory Authority (BoMRA) Was established through the Medicines and Related Substances Act of 2013. The MRSA Authorises BoMRA to perform functions given by the shareholder – The Government of Botswana. The MRSA of 2013 replaced the repealed Drugs and Related Substances Act No.
Designed And Developed By Ntebogang Technologies
COVID-19 Updates
 Covid19 Updates